Skip to main content
Header Nav
  • About
    • About Us
    • Vision and Values
    • Meet the Team
  • Products
  • Pipeline
  • Impact
  • Investors
  • Careers
  • Contact us
Specializing in Injectables
Header Nav
  • About
    • About Us
    • Vision and Values
    • Meet the Team
  • Products
  • Pipeline
  • Impact
  • Investors
  • Careers
  • Contact us
Investors Menu
Investor Relations
  • Investor Center Home
  • Press Releases
  • Corporate Governance
    • Policies and Charters
    • Board of Directors
    • Board Committee Assignments
    • Leadership Team
  • Stock Information
    • Stock Quote
    • Stock Chart
    • Historical Stock Quote
    • Investment Calculator
  • SEC Filings
  • Events & Presentations
  • Annual Reports
  • Investor FAQs
  • Contact IR

Event Details

Annual Stockholder Meeting

10/17/25 at 10:00 AM EDT

Supporting Materials

Annual Meeting Notice and Proxy Statement 474 KB
Notice 145.2 KB
Proxy Card 52 KB
Eagle Pharmaceuticals Inc. 2024 and 2023 Audited Financials 663.1 KB
Unaudited First Quarter 2025 Financial Statements 453.8 KB
Unaudited Second Quarter 2025 Financial Statements 411.7 KB
Change % Volume Data as of 03/30/2026 10:54 PM EDT Data Provided by Refinitiv. Minimum 15 minutes delayed.
Investor Relations
  • Investor Center Home
  • Press Releases
  • Corporate Governance
    • Policies and Charters
    • Board of Directors
    • Board Committee Assignments
    • Leadership Team
  • Stock Information
    • Stock Quote
    • Stock Chart
    • Historical Stock Quote
    • Investment Calculator
  • SEC Filings
  • Events & Presentations
  • Annual Reports
  • Investor FAQs
  • Contact IR
Sidebar Links
  • Email Alerts
  • RSS Feeds

Investor Contact

In-Site
Communications, Inc.
Lisa M. Wilson,
212-452-2793

For all other media inquiries, please contact us.

Footer Links
  • privacy policy
  • terms of use
  • sitemap
  • contact us

© 2026 Eagle Pharmaceuticals, Inc. All rights reserved. Woodcliff Lake, NJ 07677